全球外科粘合劑市場-2022-2029
市場調查報告書
商品編碼
1140708

全球外科粘合劑市場-2022-2029

Global Surgical Glue Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

外科粘合劑市場規模預計將在 2021 年達到 52.8 億美元,在 2029 年達到 91.3 億美元,在預測期間(2022-2029 年)以 7.64% 的複合年增長率增長。

手術膠(也稱為手術密封劑或粘合劑)用於在手術或創傷後將外部和內部組織固定在一起。手術粘合劑可以與縫合線和釘書釘結合使用或作為其替代品。它使用化學鍵將組織固定在一起以進行癒合或充當阻止體液流動的屏障。外科粘合劑市場的進步主要是為了解決傳統傷口閉合技術的局限性。此外,由於手術粘合劑具有良好的生物學和物理特性,越來越多的外科醫生正在使用這種技術來密封傷口。外科膠水來源於幾種天然生物聚合物,如明膠、膠原蛋白、殼聚醣、白蛋白和纖維蛋白。

市場動態

市場的增長受到各種因素的推動,例如外科手術和燒傷數量的增加、全球道路交通事故發生率的增加以及健康意識的提高。

預計手術數量增加和創傷增加將推動市場增長。

創傷的增加將使市場活躍起來。此外,全球外科手術和燒傷數量的增加以及交通事故數量的增加是市場增長的主要驅動力。健康意識的提高和疾病(如皮膚病、癌症、心髒病和呼吸系統疾病)的高發病率正在增加手術干預的機會。

根據世界衛生組織(WHO)2020年報告,估計每年約有135萬人死於交通事故。還估計有 20-5000 萬人遭受非致命傷害,其中許多人因受傷致殘。世界上 93% 的道路死亡事故發生在低收入和中等收入國家,儘管他們佔世界汽車總數的 60%。即使在高收入國家,社會經濟背景較低的人也更有可能捲入交通事故。因此,預計疾病流行率的增加以及道路傷害案件將推動市場。

此外,這些設備在全球範圍內具有無數的可訪問性和可用性,這是外科粘合劑市場增長的主要原因之一。由於可支配收入的增加和這些國家居民的健康問題日益嚴重,發達國家和發展中國家的公民都在醫療保健服務上進行了大量支出。

美國疾病控制與預防中心 (CDC) 最近發布的一項研究表明,美國醫療保健服務的總支出預計將達到 3.9 萬億美元。英國國家統計局 (ONS) 的一份報告發現,過去英國的醫療保健總成本約為 3000 億美元。

上述數據表明,由於醫療意識的提高、可支配收入的增加以及外科設施的各種發展,各國正在增加對醫療保健和相關設施的支出。因此,患有各種疾病的患者正在接受手術(一種更好、更快的治療選擇),這推動了全球手術粘合劑市場的增長。

與手術粘合劑相關的副作用和法律複雜性預計將阻礙市場增長

外科粘合劑對其可用性和安全性有一些限制,包括過敏反應、清創和皮膚感染。它也被 FDA 歸類為 II 類,在印度的藥品和化妝品法案 (1940) 下被歸類為 B 類,並且有點風險,需要進行臨床試驗並導致進一步的法律並發症。這些材料的安全性、質量和性能需要出於公共衛生目的進行嚴格評估,因此需要遵守複雜而嚴格的附屬機構規定。因此,這些因素阻礙了外科粘合劑市場的增長。

行業分析

全球外科粘合劑市場基於波特五力、監管分析、供應鏈分析和定價分析等各種行業因素對市場進行了深入分析。

細分分析

氰基丙烯酸酯部分預計將在全球外科粘合劑市場佔有最大的市場份額

全球外科粘合劑市場按纖維蛋白、膠原蛋白、明膠、氰基丙烯酸酯、聚合物水凝膠和聚氨酯粘合劑進行細分。氰基丙烯酸酯部分佔據最大的市場份額。氰基丙烯酸酯是一種粘性物質,存在於許多類型的粘合劑中。攝入該物質或與皮膚接觸會導致中毒。激活塗藥器,將氰基丙烯酸酯粘合劑塗在潮濕的組織上,然後發生聚合反應。我們氰基丙烯酸酯設備的一個特點是在聚合開始時僅產生少量熱量。因此,您不會體驗到其他公司產品中的刺痛感或刺痛感。

氰基丙烯酸酯粘合劑具有生物相容性,不需要去除,因為它們會在傷口癒合過程中從皮膚上自然脫落。氰基丙烯酸酯的特性,即與皮膚表面粘合的快速固化、高強度聚合物,具有柔韌性、耐用性、防水性和凝固時的透明性,使氰基丙烯酸酯成為傷口閉合和皮膚屏障產品的理想選擇。我正在製作東西。氰基丙烯酸酯可以非侵入性地閉合傷口,並且比傳統的傷口閉合方法對患者的侵入性更小。常用於腹腔鏡切口閉合,比纖維蛋白密封劑或縫合線強得多。氰基丙烯酸酯防水、柔韌且不需要傷口敷料。

在預測期內,纖維蛋白膠領域預計將出現積極的市場增長。纖維蛋白膠是一種源自人類和動物(牛)血液製品的外科粘合劑。纖維蛋白密封劑的成分在應用時相互作用,形成由纖維蛋白血液蛋白製成的凝塊。纖維蛋白密封劑在心血管手術、肺部手術、硬腦膜閉合(覆蓋大腦和脊髓的纖維膜)中有效,並可用於閉合脾臟和肝臟的撕裂傷。

纖維蛋白密封劑還用於止血過程,以控製手術期間和手術後的出血,使其成為纖維蛋白密封劑的市場領導者之一。纖維蛋白封閉劑由纖維蛋白原和凝血□組成,在嚴重出血時的止血過程中起重要作用。 .纖維蛋白密封劑是 FDA 批准用於臨床的唯一一種商業可用材料,可用作止血劑和粘合劑。據說纖維蛋白密封劑是世界上使用最多的止血劑。

此外,市場還根據心血管外科、骨科外科、普通外科、整容外科、肺外科、中樞神經外科等進行細分。心血管外科擁有最大的市場份額。疾病發病率的上升相應地推動了手術數量的增加,從而促進了全球手術中的手術粘合劑,主要是心血管手術。多年來,這一直是大多數提供外科服務的醫療中心的標準程序。不斷增加的範圍和數量的外科手術在該領域處於領先地位。

世界人口日益老齡化是該領域的主要驅動力之一。根據世衛組織的數據,2015 年至 2050 年間,世界老年人口預計將翻一番,從 12.0% 增加到 22.0%。老年人群的血管功能障礙和先天性畸形的增加預計將推動市場。此外,缺乏運動和不健康的生活方式也會增加心血管疾病的發病率。

根據美國心臟協會的調查,2016 年美國死於心血管疾病的人數超過 8,000 人。已證實這些疾病奪走的生命比慢性下呼吸道疾病和癌症加起來還要多。每天約有 2,300 名美國人死於心血管疾病,平均每 38 秒就有 1 人死亡。這些因素將推動該細分市場的增長。

預計整容手術部門在預測期內將見證積極的市場增長。這是由於在整容手術和燒傷手術中越來越多地使用手術粘合劑。隨著更多的面部整容手術、更多的皮膚損傷病例、更高的燒傷發生率以及全球更多接受乳房切除術和乳房重建手術的乳腺癌患者,預計這一數字將進一步上升。預計這些因素將在預測期內推動市場增長。

區域分析

北美佔全球外科粘合劑市場的最大市場份額。

按地區劃分,全球外科粘合劑市場分為北美、南美、歐洲、亞太地區、中東和非洲。在所有地區中,北美在全球外科粘合劑市場中占主導地位,預計在預測期內將以最高的複合年增長率增長。預計北美仍將是未來幾年增長率最高的外科粘合劑市場。增長的動力來自於對醫用粘合劑研發投資的增加及其在該地區進行的各種外科手術中的應用。根據 2020 年心髒病和中風統計情況說明書,估計美國每年至少有 40,000 名嬰兒受到先天性心髒病的影響。其中,大約 25% 或 2.4(每 1,000 名活產嬰兒)需要在出生後的第一年內接受治療。此外,美國對整容手術的需求和關注度不斷提高,以及對預防和矯正治療的認識不斷提高,也推動了該地區的市場增長。

亞太地區預計將佔據第三大市場份額,因為其患者人數眾多、熟練技術人員相對便宜,以及有利於快速產品批准的監管框架。此外,印度、中國和馬來西亞蓬勃發展的醫療旅遊業預計將推動對手術粘合劑的需求。

競爭格局

由於存在多個國際和國內市場,全球外科粘合劑市場競爭激烈。產品多樣化、貨幣化和機會使市場更具競爭力。B. Braun Melsungen AG、Baxter International Inc、Advanced Medical Solutions Group PLC、CR Bard Inc、Cardinal Health Inc、CryoLife Inc、Integra Lifesciences Holdings Corporation、Cothera Medical Inc、Takeda Pharmaceutical Company Limited、Johnson &Johnson、Medtronic PLC具有市場份額的主要市場參與者。主要參與者正在利用產品開發、新產品發布、市場擴張和產品多元化戰略來保持其市場地位。

公司通過合作、合併、戰略夥伴關係和收購來擴大其影響力並滿足全球對外科粘合劑不斷增長的需求。例如:

  • 2021 年 7 月,Baxter收購了 PerClot 多醣止血系統,通過主動和被動止血解決方案增加了其先進的手術產品組合。
  • 2019 年 6 月,Technion-Israel Institute of Technology 的研究人員宣布,他們開發出一種無毒、可生物降解且具有柔韌性的新型外科粘合劑。這種新產品適用於內部和外部手術。儘管它已成為外科縫合器和縫合線的可靠替代品,但外科粘合劑通常僅在體外使用。

值得關注的主要公司

B. Braun Melsungen AG:

描述 簡介 生產醫療器械和藥品的德國公司。公司總部位於德國梅爾松根,成立於 1839 年。它在大約 60 個國家提供服務,擁有大約 63,000 名員工。約5,000種保健品。

產品介紹

Histoacrylic 是一種組織粘合劑,含有單體 2-氰基丙烯酸正丁酯,在與組織液接觸後立即聚合。它有兩種顏色:適合塗抹於面部的半透明和易於控制塗抹量的藍色。

重大發展。2020 年 6 月,B. Brown 宣布擴大其針對醫療保健解決方案的測試能力組合。

全球外科粘合劑市場報告提供了大約 45 多個市場數據表、40 多個數字和 180 頁的組成。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查目的和範圍

第二章市場定義和概述

第三章執行摘要

第四章市場動態

  • 市場影響因素
    • 促進者
      • 交通事故數量增加
      • 增加外科手術
    • 抑製劑
      • 與手術膠相關的副作用
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析

第 6 章 按產品分類

  • 天然粘合劑
    • 毛布林
    • 明膠
    • 膠原
  • 合成粘合劑
    • 氰基丙烯酸酯
    • 水凝膠
    • 聚氨酯系統

第 7 章 適應症/效果

  • 止血
  • 組織阻滯
  • 組織工程

第 8 章 按用途

  • 心血管外科
  • 普通外科
  • 神經外科
  • 呼吸
  • 整形外科
  • 骨科
  • 眼科
  • 傷口處理
  • 其他

第 9 章最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第 11 章 競爭格局

  • 競爭情景
  • 市場定位/市場份額分析
  • 併購分析

第十二章公司簡介

  • B. Braun Melsungen AG
    • 公司簡介
    • 產品組合和描述
    • 主要發展狀況
    • 財務概覽
  • Baxter International Inc.
  • Advanced Medical Solutions Group PLC
  • C. R. Bard Inc
  • Cardinal Health Inc.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corporation
  • Cohera Medical Inc.
  • Takeda Pharmaceutical Company Limited.
  • Medtronic PLC.

第 13 章全球外科粘合劑市場-DataM

簡介目錄
Product Code: DMHOS2605

Market Overview

Surgical Glue Market size was valued US$ 5.28 billion in 2021 and is estimated to reach US$ 9.13 billion by 2029, growing at a CAGR of 7.64% during the forecast period (2022-2029).

Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop bodily fluids flow. Advancements in the surgical glue market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to surgical glue's favorable biological and physical properties, more surgeons are using this technique to seal wounds. Surgical glue is derived from several natural biopolymers, including gelatin, collagen, chitosan, albumin, and fibrin.

Market Dynamics

The market growth is driven by various factors such as rise in the number of surgical procedures and burn cases and increasing incidences of road accidents globally and rising health awareness.

Increasing number of surgical procedures and rising traumatic injuries are expected to drive market growth.

The rising number of traumatic injuries drives the market. The market growth is also majorly driven by the rise in the number of surgical procedures and burn cases and increasing incidences of road accidents globally. The rising health awareness and high prevalence of diseases (such as skin diseases, cancer, heart diseases, and respiratory diseases) have increased the opportunities for surgeries.

According to the World Health Organization (WHO) 2020 report, estimates approximately 1.35 million people die each year due to road traffic crashes. 20 to 50 million people suffer from non-fatal injuries, with many incurring a disability resulting from their injury. 93% of the world's fatalities on the roads occur in low and middle-income countries, even though they have approximately 60% of the world's vehicles. Even within high-income countries, individuals from lower socioeconomic backgrounds are more likely to be involved in road traffic crashes. Thus, the rising prevalence of diseases along with road injury cases is expected to drive the market.

Additionally, there are innumerable accessibility and availability of these devices across the globe, which is one of the major reasons for the growth of the surgical glue market. It has been observed that the citizens of both developed and developing countries are extensively spending on healthcare services due to the increasing disposable income of the residents of those countries and increasing health issues.

According to a recent study published by the Centers for Disease Control and Prevention (CDC), it has been established that the total expenditure on healthcare services in the U.S. has projected towards a total of $3.9 trillion. Moreover, according to a report furnished by the U.K. Office for National Statistics (ONS), the U.K.'s total healthcare expenditure accounted for approximately $300 billion in the recent past.

The abovementioned data indicate that countries are increasingly spending on healthcare and related facilities owing to rising medical awareness, growth in disposable income, and various developments in surgical facilities. Thus, patients suffering from various diseases are going for surgeries (better and quick treatment options), which drives the global surgical glue market growth.

Side effects associated with surgical glue and legal complexities expected to hamper the growth of market

Surgical glue has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. Besides, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the surgical glue market.

Industry Analysis

The global surgical glue market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis.

Segment Analysis

Cyanoacrylates segment is expected to hold the largest market share in global surgical glue market

The global surgical glue market is segmented on fibrin, collagen, gelatin, cyanoacrylate, polymeric hydrogel, and urethane-based adhesive. The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many types of glue. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue, the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low heat level is generated when this polymerization starts. Consequently, the patient does not experience the stinging or burning sensation that occurs with some competitor products.

Cyanoacrylate glue is biocompatible and does not need removal as it naturally slough off the skin as part of the natural wound healing process. Cyanoacrylate properties, namely fast-setting, high tensile strength polymers that bind with the skin's surface and are flexible, durable, waterproof, and transparent on the setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and enhance the patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible, and require no dressing on the wound.

The fibrin glue segment is expected to have positive market growth in the forecast period. Fibrin glue is a type of surgical adhesive derived from both human and animal (bovine) blood products. Ingredients in the fibrin sealant interact during application to form a clot made from fibrin's blood protein. Fibrin sealants are effective for cardiovascular surgery, lung surgery, and closure of the Dural (a fibrous membrane covering the brain and spinal cord) and can be used to close spleen and liver lacerations.

Fibrin sealant is also used in hemostasis processes to control bleeding during and after surgical procedures, one of the leading fibrin sealants market trends. Fibrin sealant comprises fibrinogen and thrombin, which play a vital role in the hemostasis process during severe bleeding. . Fibrin sealant is the only commercially available FDA-approved material for clinical use a hemostat sealant and adhesive. Fibrin sealants are referred to as the most adopted hemostats worldwide.

Further, the market is also classified based on cardiovascular surgery, orthopedic surgery, general surgery, cosmetic surgery, pulmonary surgery, central nervous system surgery, and others. The cardiovascular surgery segment is held the largest market share. The rise in the incidence of diseases correspondingly drives the number of surgical procedures performed, thereby boosting surgical glues in surgeries and, mainly, cardiovascular procedures globally. It has been a standard procedure in most medical centers providing surgical services for several years. Both the range and the number of surgical procedures performed are constantly increasing, driving the segment.

The globally increasing aging population is one of the major drivers of this segment. According to WHO, the world's geriatric population is expected to nearly double from 12.0% to 22.0% between 2015 and 2050. The market is expected to be driven by a vascular malfunction in the geriatric population and a rise in congenital disabilities. Furthermore, physical inactivity and an unhealthy lifestyle are also increasing the incidence of cardiovascular conditions.

According to the American Heart Association Research, cardiovascular diseases accounted for more than 8 lakh deaths in the U.S. in 2016. It has been observed that these diseases claim more lives than chronic lower respiratory disease and cancer combined. Approximately 2,300 Americans die due to cardiovascular diseases each day, an average of one death every 38 seconds. This factor will drive the growth of the segment.

The cosmetic surgery segment is expected to have positive market growth in the forecast period. This is due to the increasing adoption of surgical glue for cosmetic procedures and burns treatment surgeries. It is further set to increase with the increasing number of facial cosmetic surgeries, increasing cases of skin injuries, growing incidence of burn injuries, and an increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures across the globe. This factor will drive the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global surgical glue market

By region, the global surgical glue market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global surgical glue market and is expected to grow at the highest CAGR during the forecast period. North America is anticipated to continue being the largest-growing surgical glue market in the coming years. The factors contributing to the growth include the increasing investments in R&D of medical adhesives and their several applications in different surgeries performed in the region. As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25%, or 2.4 (per 1,000 live births), require treatment in the first year of life. Moreover, the increasing demand for and focus on cosmetic surgery and its growing awareness of preventative and corrective treatment in the USA are driving the growth of the market in this region.

The Asia-Pacific region is expected to have the third-largest share due to a large patient pool, availability of skilled technicians at a comparatively lower price, and a defined regulatory framework favoring expedited product approvals. Furthermore, the booming medical tourism industry in India, China, and Malaysia is expected to boost demand for surgical glue.

Competitive Landscape

The global surgical glue market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition B. Braun Melsungen AG, Baxter International Inc., Advanced Medical Solutions Group PLC, C. R. Bard Inc., Cardinal Health Inc., CryoLife Inc., Integra Lifesciences Holdings Corporation, Cohera Medical Inc., Takeda Pharmaceutical Company Limited., and Johnson & Johnson, Medtronic PLC. are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies enter into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for surgical glue across the globe. For instance,

  • In Jul 2021, Baxter acquired PerClot polysaccharide hemostatic system to increase its advanced surgery portfolio with active and passive hemostatic solutions.
  • In June 2019, the research team at Technion - Israel Institute of Technology announced that they had developed a new surgical glue that is non-toxic, biodegradable, and flexible. The new product is compatible with both internal as well as external surgeries. Despite emerging as a reliable alternative for surgical staplers and sutures, surgical glue is typically used only for external applications.

Key Companies to Watch

B. Braun Melsungen AG:

Overview: B. Braun is German company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and founded in 1839. They provide services in around 60 countries that employees around 63,000 people. They have aroubd 5,000 variety of healthcare products.

Product Portfolio:

Histoacryl: It is a tissue adhesive which contains monomeric n-butyl-2-cyanoacrylate, that quickly polymerises in connection to tissue fluid. It can be found in two colours: translucent, that is specially designed for facial application and blue, that provides easy control over the amount applied.

Key Developments: In Jun 2020, B. Braun announced about extending its portfolio of healthcare solutions testing capabilities.

The global surgical glue market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Increasing Incidences of Road Accidents
      • 4.1.1.2. Growing Number of Surgical Procedures
    • 4.1.2. Restraints:
      • 4.1.2.1. Side Effects Associated with Surgical Glue
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Natural adhesive
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 6.2.3. Firbrin
    • 6.2.4. Gelatin
    • 6.2.5. Collagen
  • 6.3. Synthetic adhesive
    • 6.3.1. Cyanoacrylates
    • 6.3.2. Hydrogel
    • 6.3.3. Urethane based

7. By Indication

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Segment
    • 7.1.2. Market Attractiveness Index, By Indication Segment
  • 7.2. Hemostasis
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tissue Sealing
  • 7.4. Tissue Engineering

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular Surgery
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. General Surgery
  • 8.4. Neuro Surgery
  • 8.5. Pulmonary
  • 8.6. Plastic surgery
  • 8.7. Orthopedic
  • 8.8. Ophthalmology
  • 8.9. Wound Management
  • 8.10. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centres
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. The U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Developments
    • 12.1.4. Financial Overview
  • 12.2. Baxter International Inc.
  • 12.3. Advanced Medical Solutions Group PLC
  • 12.4. C. R. Bard Inc
  • 12.5. Cardinal Health Inc.
  • 12.6. CryoLife Inc.
  • 12.7. Integra LifeSciences Holdings Corporation
  • 12.8. Cohera Medical Inc.
  • 12.9. Takeda Pharmaceutical Company Limited.
  • 12.10. Medtronic PLC.

LIST NOT EXHAUSTIVE

13. Global Surgical Glue Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Method of Fixation
  • 13.3. Contact Us